Skip to main content
. 2024 Oct 1;9:180. doi: 10.1038/s41541-024-00979-w

Fig. 4. The recombinant nanoplasmid expressing hGPRC5D as a DNA vaccine candidate.

Fig. 4

A Flow cytometry analysis of exogenous hGPRC5D expressed in 293T or B16-F10 cells transfected with Nano-hGPRC5D or pUltraHot-hGPRC5D. B, C Flow cytometry and western blot analysis of hGPRC5D expression in mouse cells stably expressing hGPRC5D. D Western blot analysis of hGPRC5D expression in the muscle of C57/BL6J mice immunized with Nano-EGFP or Nano-hGPRC5D.